Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
New
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
for
Chin Augmentation
Location: Nashville TN, Atlanta GA, Spring TX, Boynton Beach FL,
Sponsor: Galderma R&D
Sex: All
Age: 22+
Code: NCT07566286
Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
for
Primary Myelofibrosis,
Location: Nashville TN, Ann Arbor MI, Houston TX, New York NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06517875
Phase2, Recruiting
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
for
Neoplasms
Location: Nashville TN, Fort Wayne IN, Myrtle Beach SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06551142
Phase1, Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Nashville TN, Avon IN, Grand Rapids MI,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06752681
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Nashville TN, Louisville KY, Atlanta GA, Cincinnati OH,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05914116
Phase1, Phase2, Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Nashville TN, Durham NC, Ann Arbor MI, Cleveland OH,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Nashville TN, Bowling Green KY, Chattanooga TN,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Nashville TN, Birmingham AL, Fairway KS, Detroit MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase1, Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
for
Solid Tumor, Adult
Location: Nashville TN, Huntersville NC, Chicago IL,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06554795
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
for
Multiple Myeloma
Location: Nashville TN, Bridgeton MO, Macon GA, Springfield MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07227311
Phase2, Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
for
Neoplasms, Colorectal, Neoplasms
Location: Nashville TN, Canton OH, Detroit MI, Hamilton, Toronto,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07213609
Phase1, Phase2, Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Nashville TN, Louisville KY, Indianapolis IN,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Nashville TN, Atlanta GA, Cincinnati OH, Goshen IN,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase2, Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Location: Nashville TN, St Louis MO, Lake Mary FL,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06545942
Phase1, Recruiting
A Study of PHN-012 in Patients With Advanced Solid Tumors
for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Nashville TN, St Louis MO, Durham NC, Fairfax VA,
Sponsor: Pheon Therapeutics
Sex: All
Age: 18+
Code: NCT07127874
Phase1, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Nashville TN, Chattanooga TN, Canton OH, Chapel Hill NC,